Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 6, 1999, Pages 1835-1842

  Ewig, Santiago ^a   Ruiz, Mauricio ^a   Torres, Antoni ^a   Marco, Francesc ^a   Martinez, Jose Antonio ^a   Sanchez, Miguel ^a   Mensa, Josep ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

AGE; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; COMORBIDITY; COMPLICATION; CONTROLLED STUDY; DISEASE SEVERITY; HOSPITALIZATION; HUMAN; IMMUNOCOMPETENCE; INTRAVENOUS DRUG ADMINISTRATION; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0033022107     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.6.9808049     Document Type: Article

References (30)

1. 1. British Thoracic Society and the Public Health Laboratory Service. 1987. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q. J. Med. 239:195-220.
2. 2. Örtquist, A., J. Hedlund, L. Grillner, E. Jalonen, I. Kallings, M. Leionen, and M. Kalin. 1990. Aetiology, outcome and prognostic factors in patients with community acquired pneumonia requiring hospitalisation. Eur. Respir. J. 3:1105-1113.
3. 3. Fang, G. D., M. Fine, J. Orloff, D. Arisumi, V. L. Yu, W. Kapoor, J. T. Grayston, S. P. Wang, R. Kohler, R. R. Muder, Y. C. Yee, J. D. Rihs, and R. M. Vickers. 1990. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multi-center study of 359 cases. Medicine 69:307-316.
4. 4. Redd, S. C., G. W. I. Rutherford, M. A. Sande, A. R. Lifson, W. K. Hadley, R. R. Facklam, and J. S. Spika. 1990. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J. Infect. Dis. 162:1012-1017.
5. 5. Burack, J. H., J. A. Hahn, D. Saint-Maurice, and M. Jakobson. 1994. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Am. J. Med. 154:2589-2596.
6. 6. LaCroix, A. Z., S. Lipson, T. P. Miles, and L. White. 1989. Prospective study of pneumonia hospitalisations and mortality of US older people: role of chronic conditions, health behaviours, and nutritional status. Public Health Rep. 104:350-360.
7. 7. Moine, P., J. B. Vercken, S. Chevret, P. Gajdos, and the French Study Group of Community-Acquired Pneumonia in ICU. 1995. Severe community-acquired pneumonia. Scand. J. Infect. Dis. 27:201-206.
8. 8. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumaniae: an overview. Clin. Infect. Dis. 15:77-83.
9. 9. Baquero, F. 1995. Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview. Microb. Drug Resist. 1:115-120.
10. 10. Geslin, P., A. Buu-Hoi, A. Fremaux, and J. F. Acar. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an epidemioogical survey in France 1970-1990. Clin. Infect. Dis. 15:95-98.
11. 11. Bedos, J. P., S. Chevret, C. Chastang, P. Geslin, and B. Regnier. 1996. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin. Infect. Dis. 22:63-72.
12. 12. Pallares, R., F. Gudiol, J. Linares, J. Ariza, G. Rufi, L. Murgui, J. Dorca, and P. F. Vildadrich. 1987. Risk factors and response to antibiotic therapy in adults with bacterial pneumonia caused by penicillin-resistant pneumococci. N. Engl. J Med. 317:18-22.
13. 13. Fenoll, A., C. M. Bourgon, R. Munoz, D. Vicisio, and J. Casal. 1991. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev. Infect. Dis. 13:56-60.
14. 14. Garcia-Leoni, M. E., E. Cercenado, P. Rodeno, J. C. L. Bernaldo de Quiros, D. Martin-Hernandez, and E. Bouza. 1992. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin. Infect. Dis. 14:427-435.
15. 15. Linares, J., R. Pallares, T. Alonso, J. L. Perez, J. Ayats, F. Gudiol, P. F. Viladrich, and R. Martin. 1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin. Infect. Dis. 15:99-105.
16. 16. Pallares, R., J. Linares, M. Vadillo, C. Cabellos, F. Manresa, P. F. Viladrich, R. Martin, and F. Gudiol. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
17. 17. Clavo-Sanchez, A. J., J. A. Giron-Gonzalez, D. Lopez-Prieto, J. Canueto-Quintero, A. Sanchez-Porto, A. Vergara-Campos, P. Marin Casanova, and J. A. Cordoba-Dona. 1997. Multivariate analysis of risk factors for infection due to penicllin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin. Infect. Dis. 24:1052-1059.
18. 18. Spika, J.S., R. R. Facklam, B. D. Pilkaytis, and M. J. Oxtoby. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J. Infect. Dis. 163:1273-1278.
19. 19. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliot, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. J.A.M.A. 271:1831-1835.
20. 20. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
21. 21. Thornsberry, C., S. D. Brown, Y. C. Yee, S. K. Bouchillon, J. K. Marler, and T. Rich. 1993. Increasing penicillin resistance in Streptococcus pneumoniae in the U.S.: effect on susceptibility to oral cephalosporins. Infect. Med. 10(D Suppl.): 15-24.
22. 22. Meynard, J. L., F. Barbut, L. Blum, M. Guiget, C. Chouaid, M. C. Meyohas, O. Picard, J. C. Petit, and J. Frottier. 1996. Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus. Clin. Infect. Dis. 22:437-440.
23. 23. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, K. M. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644-1655.
24. 24. Murray, T. J., and J. A. Washington. 1975. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin. Proc. 50:339-344.
25. 25. Balows, A., and W. J. Harsier, Jr. 1991. Manual of Clinical Microbiology, 5th ed., section III. American Society of Microbiology, Washington, DC. 209-553.
26. 26. National Committee for Clinical Laboratory Standards. 1997. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically, 4th ed. National Committee for Clinical Laboratory Standards, Wayne, PA. M7-A4.
27. 27. Fine, M. J., T. E. Auble, D. M. Yealy, B. H. Hanusa, L. A. Weissfeld, D. E. Singer, C. M. Coley, T. J. Marrie, and W. N. Kapoor. 1997. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336:243-250.
28. 28. Garcia de Lomas y grupo Espanol para vigilancia de patogcnos respiratorios. 1998. Situacion epidemiologica actual y resistencia de los patogenos respiratorios en Espana. Med. Clin. (Barc.) 110(Suppl. 1):44-51.
29. 29. Nava, J. M., F. Bella, J. Garau, J. Lite, M. Morera, and C. Marti. 1994. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin. Infect. Dis. 19: 884-890.
30. 30. Klugman, K. P., and C. Feldman. 1997. The clinical relevance of antibiotic resistance in the management of pneumococcal pneumonia. Clin. Pulm. Med. 4:190-193.